RadNet Resultados de beneficios anteriores

Pasado controles de criterios 1/6

Los beneficios de RadNet han disminuido a una tasa media anual de -27.4%, mientras que en la industria Healthcare los beneficios crecieron en un 7.1% anualmente. Los ingresos han ido creciendo a una tasa media de 9.5% al año. La rentabilidad financiera de RadNet es de 3.7%, y sus márgenes netos son de 0.2%.

Información clave

-27.4%

Tasa de crecimiento de los beneficios

-29.5%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	8.5%
Tasa de crecimiento de los ingresos	9.5%
Rentabilidad financiera	3.7%
Margen neto	0.2%
Próxima actualización de resultados	09 May 2024

Actualizaciones de resultados anteriores recientes

Recent updates

An Intrinsic Calculation For RadNet, Inc. (NASDAQ:RDNT) Suggests It's 41% Undervalued

Nov 26

RadNet JV acquires Montclair Radiology's outpatient radiology assets

Oct 11

Some Investors May Be Worried About RadNet's (NASDAQ:RDNT) Returns On Capital

Oct 10

RadNet Presents With The Idiosyncratic Risk Premia To Deliver Risk-Adjusted Alpha

Aug 28

Here's Why RadNet (NASDAQ:RDNT) Has A Meaningful Debt Burden

Aug 12

RadNet Non-GAAP EPS of $0.15 beats by $0.06, revenue of $354.1M beats by $5.16M;reaffirms FY guidance

Aug 09

RadNet (NASDAQ:RDNT) Is Reinvesting At Lower Rates Of Return

Jul 01

Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?

Jun 17

Is RadNet (NASDAQ:RDNT) A Risky Investment?

May 11

Estimating The Intrinsic Value Of RadNet, Inc. (NASDAQ:RDNT)

Apr 06

Is RadNet (NASDAQ:RDNT) Using Too Much Debt?

Jan 24

Returns On Capital At RadNet (NASDAQ:RDNT) Have Stalled

Dec 23

Is RadNet, Inc. (NASDAQ:RDNT) Potentially Undervalued?

Dec 08

RadNet, Inc.'s (NASDAQ:RDNT) Intrinsic Value Is Potentially 35% Above Its Share Price

Nov 23

RadNet (NASDAQ:RDNT) Has A Pretty Healthy Balance Sheet

Oct 22

RadNet: An Essential Healthcare Services Stock Seen Underpriced By Market-Makers

Sep 03

Returns At RadNet (NASDAQ:RDNT) Appear To Be Weighed Down

Sep 01

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero RadNet. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NasdaqGM:RDNT Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	1,617	3	142
30 Sep 23	1,580	4	120
30 Jun 23	1,528	-13	121
31 Mar 23	1,479	-13	123
31 Dec 22	1,430	11	144
30 Sep 22	1,382	8	92
30 Jun 22	1,365	23	61
31 Mar 22	1,344	18	0
31 Dec 21	1,324	25	0
30 Sep 21	1,297	35	108
30 Jun 21	1,256	24	55
31 Mar 21	1,138	11	81
31 Dec 20	1,098	-15	0
30 Sep 20	1,090	-10	106
30 Jun 20	1,091	-13	108
31 Mar 20	1,164	2	133
31 Dec 19	1,154	15	0
30 Sep 19	1,111	33	24
30 Jun 19	1,060	35	99
31 Mar 19	1,015	36	90
31 Dec 18	975	32	0
30 Sep 18	953	-4	85
30 Jun 18	939	-6	83
31 Mar 18	925	-6	59
31 Dec 17	922	0	0
30 Sep 17	912	11	77
30 Jun 17	909	9	74
31 Mar 17	897	7	75
31 Dec 16	885	7	74
30 Sep 16	875	5	75
30 Jun 16	859	11	76
31 Mar 16	845	11	74
31 Dec 15	810	8	72
30 Sep 15	779	11	70
30 Jun 15	755	7	68
31 Mar 15	730	9	66
31 Dec 14	718	1	64
30 Sep 14	710	-2	63
30 Jun 14	701	-7	63
31 Mar 14	699	-9	64
31 Dec 13	703	2	65
30 Sep 13	684	53	65
30 Jun 13	669	58	63

Ingresos de calidad: RDNT tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(0.2%) de RDNT son inferiores a los del año pasado (0.7%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de RDNT han disminuido en un 27.4% al año en los últimos 5 años.

Acelerando crecimiento: RDNT ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: RDNT tuvo un crecimiento negativo de los beneficios (-71.4%) durante el año pasado, lo que dificulta la comparación con la media de la industria Healthcare (7.1%).

RadNet Resultados de beneficios anteriores

Pasado controles de criterios 1/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2023 earnings: EPS misses analyst expectations

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: EPS misses analyst expectations

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Recent updates

RadNet, Inc., Annual General Meeting, Jun 12, 2024

Price target increased by 7.0% to US$53.33

Are RadNet, Inc. (NASDAQ:RDNT) Investors Paying Above The Intrinsic Value?

Now 21% overvalued after recent price rise

RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $200.2 million.

Consensus EPS estimates increase by 12%

RadNet, Inc.'s (NASDAQ:RDNT) 26% Price Boost Is Out Of Tune With Revenues

Price target increased by 12% to US$45.80

Now 21% overvalued after recent price rise

Full year 2023 earnings: EPS misses analyst expectations

Why RadNet, Inc. (NASDAQ:RDNT) Could Be Worth Watching

RadNet, Inc. Stock Price Is More Vigorous Than Its Valuation

Getting In Cheap On RadNet, Inc. (NASDAQ:RDNT) Might Be Difficult

Insider recently sold US$354k worth of stock

Insider notifies of intention to sell stock

RadNet, Inc. Launches a Pilot Inside Walmart of its New MammogramNow™ Offering

We Think RadNet (NASDAQ:RDNT) Can Stay On Top Of Its Debt

RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio

RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

RadNet (NASDAQ:RDNT) Might Be Having Difficulty Using Its Capital Effectively

New major risk - Financial position

RadNet, Inc. Appoints Dr. Gregory Sorensen as Executive Vice President and Chief Science Officer

RadNet (NASDAQ:RDNT) Takes On Some Risk With Its Use Of Debt

Radnet, Inc. Revises Earnings Guidance for the Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

RadNet, Inc. Announces Appointment of Executives

Consensus EPS estimates upgraded to US$0.10 loss

RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $225.35625 million.

President & COO of Western Operations recently sold US$1.4m worth of stock

RadNet, Inc. Announces Ruth V. Wilson Did Not to Stand for Re-Election to the Board of Directors

President & COO of Western Operations exercised options to buy US$1.5m worth of stock.

RadNet, Inc., Annual General Meeting, Jun 07, 2023

Board Member recently sold US$138k worth of stock

RadNet, Inc. Revises Earnings Guidance for the Year 2023

Price target increased by 7.8% to US$34.50

We Think RadNet (NASDAQ:RDNT) Is Taking Some Risk With Its Debt

President & COO of Eastern Operations recently sold US$230k worth of stock

Insider recently sold US$443k worth of stock

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

RadNet (NASDAQ:RDNT) Will Want To Turn Around Its Return Trends

Radiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program, Providing Women A New State-Of-The-Art Solution Powered by Artificial Intelligence

President & COO of Western Operations recently sold US$97k worth of stock

RadNet (NASDAQ:RDNT) Has A Somewhat Strained Balance Sheet

An Intrinsic Calculation For RadNet, Inc. (NASDAQ:RDNT) Suggests It's 41% Undervalued

Consensus forecasts updated

Third quarter 2022 earnings: EPS misses analyst expectations

RadNet, Inc. Provides Earnings Guidance for the Full Year of 2022

Investor sentiment deteriorated over the past week

RadNet, Inc. (NasdaqGM:RDNT) acquired 75% stake in Heart & Lung Imaging Limited.

RadNet JV acquires Montclair Radiology's outpatient radiology assets

Some Investors May Be Worried About RadNet's (NASDAQ:RDNT) Returns On Capital

Price target decreased to US$32.25

Investor sentiment improved over the past week

RadNet Presents With The Idiosyncratic Risk Premia To Deliver Risk-Adjusted Alpha

Investor sentiment improved over the past week

Here's Why RadNet (NASDAQ:RDNT) Has A Meaningful Debt Burden

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

RadNet, Inc. Updates Earnings Guidance for 2022

RadNet Non-GAAP EPS of $0.15 beats by $0.06, revenue of $354.1M beats by $5.16M;reaffirms FY guidance

RadNet (NASDAQ:RDNT) Is Reinvesting At Lower Rates Of Return

Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?

President & COO of Western Operations recently sold US$205k worth of stock

RadNet, Inc. Announces That It Has Received FDA Clearances for Its DeepHeatlh Saige-DX™ Mammography and Quantib® Prostate 2.0 MRI Artificial Intelligence ("Ai") Algorithms

Consensus forecasts updated

Is RadNet (NASDAQ:RDNT) A Risky Investment?

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

RadNet, Inc. Revises Earnings Guidance for the Fiscal Year 2022

RadNet, Inc., Annual General Meeting, Jun 08, 2022

Desglose de ingresos y gastos
Beta